Best Research Peptides for Fat Loss & Metabolic Research
The GLP-1 class has made metabolic research one of the fastest-moving areas in the field. This roundup summarizes the compounds most studied for fat-loss and metabolic endpoints, with links to their calculators. Reference only — not a dosing schedule and not medical advice.
Retatrutide
An investigational GLP-1 / GIP / glucagon triple agonist studied in Phase-2/3 obesity trials. Dosed in small milligram amounts, titrated over weeks. See the Retatrutide calculator and the GLP-1 titration tool.
Tirzepatide
A GLP-1 / GIP dual agonist. Research setups commonly target 10 mg/mL or 20 mg/mL. See the Tirzepatide calculator.
Semaglutide
A GLP-1 receptor agonist studied extensively in metabolic research. Amounts are small (fractions of a milligram) — a fine syringe helps. See the Semaglutide calculator.
MOTS-c
A mitochondrial-derived peptide studied for metabolic and mitochondrial-function pathways, distinct from the GLP-1 mechanism. See the MOTS-c calculator.
A note on titration
GLP-class research references step amounts up over weeks. The GLP-1 titration calculator converts the published escalation steps into syringe units for your vial — as a measurement reference, not a recommendation.
Key takeaways
- Retatrutide, Tirzepatide, and Semaglutide are the three headline GLP-class compounds.
- MOTS-c is a separate mitochondrial-metabolic research peptide.
- GLP amounts are small and titrated — use the titration calculator to convert steps to units.
- Reference only — not a dosing recommendation or medical advice.
